| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.03B | 46.50B | 46.12B | 48.51B | 49.79B | 44.86B |
| Gross Profit | 10.41B | 10.36B | 10.39B | 11.86B | 11.93B | 11.12B |
| EBITDA | 1.80B | 3.28B | 3.01B | 4.50B | 6.57B | 5.39B |
| Net Income | 2.30B | 2.17B | 3.14B | 4.00B | 3.87B | 2.91B |
Balance Sheet | ||||||
| Total Assets | 144.01B | 148.08B | 143.26B | 142.01B | 138.14B | 137.47B |
| Cash, Cash Equivalents and Short-Term Investments | 12.51B | 12.39B | 14.48B | 18.84B | 9.68B | 13.55B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 32.00M |
| Total Liabilities | 9.93B | 10.34B | 8.01B | 9.11B | 9.56B | 9.17B |
| Stockholders Equity | 134.07B | 137.73B | 135.25B | 132.91B | 128.58B | 128.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.42B | 1.08B | 3.40B | 1.77B | 3.25B |
| Operating Cash Flow | 0.00 | 4.81B | 2.58B | 4.89B | 2.92B | 4.53B |
| Investing Cash Flow | 0.00 | -3.49B | -579.00M | -3.84B | 553.00M | -4.11B |
| Financing Cash Flow | 0.00 | -1.56B | -1.56B | -2.37B | -1.95B | -1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥16.64B | 2.31 | ― | 2.30% | 9.86% | 119.10% | |
76 Outperform | ¥513.58B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
67 Neutral | ¥66.85B | 31.55 | 1.61% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥28.02B | 3.93 | ― | 2.94% | 0.41% | -51.02% | |
54 Neutral | ¥4.29B | -27.75 | ― | 3.25% | -1.20% | -1136.47% | |
45 Neutral | ¥5.24B | -3.62 | ― | ― | -23.54% | -14.54% |